New, exotic materials: Getting oxygen into yttrium hydrides

Graphic of a material surface

The modern world is constantly hungry for new materials with properties optimised for their applications. Designing them is no trivial task and often relies on computational modelling to test whether new material structures are feasible. Dr Aleksandr Pishtshev and Evgenii Strugovshchikov from the University of Tartu, Estonia and Dr Smagul Karazhanov from the Institute for Energy Technology, Norway have been […]

Read More…

Statistics in the era of COVID-19: Measuring lockdowns with doubling time

graph and clock design

The key to understanding SARS-CoV-2 (COVID-19) transmission is understanding the exponential growth of viral transmissions. The problem is that the concept of exponential growth is challenging for many to understand and interpret, including policymakers who need to make quick and informed decisions. Dr Biljana Stangeland, Executive Director/Chief Scientific Officer at Alv B, Norway, has been using doubling time – the […]

Read More…

Multi-fidelity shape optimisation of suspension bridge decks

Dr Kusano investigates the design optimisation of long-span suspension bridges, such as the Hardanger Bridge in Norway.

Over the last century, technological advances have resulted in increased length of the main span of long-span suspension bridges, making them even more vulnerable to structural vibrations caused by environmental factors, particularly wind. Dr Ibuki Kusano from the University of Stavanger, Norway, and her collaborators are investigating the structural response of suspension bridges under wind loads. The research team has […]

Read More…

Biosimilars: An effective treatment at a lower cost

Biosimilars: An effective treatment at a lower cost

While most medications are both safe and effective, unfortunately many are also expensive. Biosimilars – new versions of a drug that are similar to the original in every meaningful way – offer a potentially less expensive alternative to costly original biological drugs. Professor Tore K. Kvien of the University of Oslo, Norway, and his colleagues have demonstrated that one biosimilar, […]

Read More…

A novel therapy could help patients with active Crohn’s disease

Dr Jahnsen's study aims to improve symptoms experienced by patients with Crohn’s disease, such as abdominal pain.

Professor Jørgen Jahnsen and PhD student Kristian Espeland of Akershus University Hospital and University of Oslo are responsible for a new clinical trial which aims to improve symptoms and control the inflammation of Crohn’s disease using Gliolan medication in combination with blue-light photopheresis. This approach will selectively cause the death of pro-inflammatory cells which contribute to the inflammatory bowel disease, […]

Read More…

Thank you for expressing interest in joining our mailing list and community. Below you can select how you’d like us to interact with you and we’ll keep you updated with our latest content.

You can change your preferences or unsubscribe by clicking the unsubscribe link in the footer of any email you receive from us, or by contacting us at at any time and if you have any questions about how we handle your data, please review our privacy agreement.

Would you like to learn more about our services?

We use MailChimp as our marketing automation platform. By clicking below to submit this form, you acknowledge that the information you provide will be transferred to MailChimp for processing in accordance with their Privacy Policy and Terms.

Subscribe to our FREE PUBLICATION